
Sign up to save your podcasts
Or


Plus ~ What to know about the substance the FDA calls "the Next Wave of the Opioid Epidemic".
What does the FDA actually do — and why does it matter to you? From regulating everything from mammograms to microwaves to navigating hot-button issues like autism treatments, Tylenol safety, and hormone replacement therapy, the FDA touches nearly every aspect of American life.
In this SmartHER News interview, FDA Commissioner Dr. Marty Makary sits down with Jenna to discuss public trust in medicine, new research on autism, the debate over acetaminophen use during pregnancy, and changing perspectives on women’s health and hormone therapy. Dr. Makary also opens up about his path from surgeon to policymaker, the challenges of modernizing the agency, and what he believes is at stake for America’s children and families.
👉 Whether you’re a parent, a patient, or just someone curious about how decisions get made in Washington, this conversation offers rare, direct insight into the FDA’s priorities — and the questions still being debated.
By Jenna Lee4.9
638638 ratings
Plus ~ What to know about the substance the FDA calls "the Next Wave of the Opioid Epidemic".
What does the FDA actually do — and why does it matter to you? From regulating everything from mammograms to microwaves to navigating hot-button issues like autism treatments, Tylenol safety, and hormone replacement therapy, the FDA touches nearly every aspect of American life.
In this SmartHER News interview, FDA Commissioner Dr. Marty Makary sits down with Jenna to discuss public trust in medicine, new research on autism, the debate over acetaminophen use during pregnancy, and changing perspectives on women’s health and hormone therapy. Dr. Makary also opens up about his path from surgeon to policymaker, the challenges of modernizing the agency, and what he believes is at stake for America’s children and families.
👉 Whether you’re a parent, a patient, or just someone curious about how decisions get made in Washington, this conversation offers rare, direct insight into the FDA’s priorities — and the questions still being debated.

2,319 Listeners

10,492 Listeners

6,713 Listeners

5,456 Listeners

21,245 Listeners

1,925 Listeners

5,373 Listeners

2,234 Listeners

65,964 Listeners

6,644 Listeners

2,269 Listeners

15,325 Listeners

4,390 Listeners

3,684 Listeners

6,026 Listeners